semaglutide and the amylin analog cagrilintide Combined GLP-1/amylin bests monotherapy for HbA1c drop, weight loss in diabetes Cagrilintide–Semaglutide in Adults with Overweight

GLP-1 drugs promise wider health benefits, but experts urge caution on use Semaglutide outperforms other GLP-1 drugs for weight loss in psychiatric populations Among those prescribed these medications for obesity, many patients discontinued treatment before reaching what the authors describe as adequate therapeutic doses

Liu D, Liao P, Li H, Tong S, Wang B, Lu Y, et al

The intranasal administration of GHK-Cu represents a novel approach aimed at overcoming the challenge of bypassing the blood-brain barrier, a common hurdle in traditional targeted neurotherapeutics (Ballabh et al., 2004

Opdivo, Bristol Myers Squibb) at 1 mg/kg and ipilimumab (anti-CTLA4